Cargando…
Gender Related Differences in the Clinical Presentation of Hypertrophic Cardiomyopathy—An Analysis from the SILICOFCM Database
Background and Objectives: Hypertrophic cardiomyopathy (HCM) is the most common inherited cardiac disease that affects approximately 1 in 500 people. Due to an incomplete disease penetrance associated with numerous factors, HCM is not manifested in all carriers of genetic mutation. Although about tw...
Autores principales: | Preveden, Andrej, Golubovic, Miodrag, Bjelobrk, Marija, Miljkovic, Tatjana, Ilic, Aleksandra, Stojsic, Snezana, Gajic, Dragan, Glavaski, Mila, Maier, Lars S., Okwose, Nduka, Popovic, Dejana, Barlocco, Fausto, Ristic, Arsen, MacGowan, Guy A., Olivotto, Iacopo, Filipovic, Nenad, Jakovljevic, Djordje G., Velicki, Lazar |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8879033/ https://www.ncbi.nlm.nih.gov/pubmed/35208637 http://dx.doi.org/10.3390/medicina58020314 |
Ejemplares similares
-
Genetic determinants of clinical phenotype in hypertrophic cardiomyopathy
por: Velicki, Lazar, et al.
Publicado: (2020) -
Design of the SILICOFCM study: Effect of sacubitril/valsartan vs lifestyle intervention on functional capacity in patients with hypertrophic cardiomyopathy
por: Tafelmeier, Maria, et al.
Publicado: (2020) -
Haemodynamic determinants of quality of life in chronic heart failure
por: Fatrin, Serlie, et al.
Publicado: (2022) -
Subtypes and Mechanisms of Hypertrophic Cardiomyopathy Proposed by Machine Learning Algorithms
por: Glavaški, Mila, et al.
Publicado: (2022) -
Insights into heart failure hospitalizations, management, and services during and beyond COVID‐19
por: Charman, Sarah J., et al.
Publicado: (2020)